Literature DB >> 10361935

The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine.

I Sedonja1, N V Budihna.   

Abstract

PURPOSE: This study compared the efficiency of SPECT with planar bone scans in differentiating malignant from benign lesions and in detecting metastases to the spine.
METHODS: Planar scintigraphy and SPECT were performed in 37 patients with low back pain without known malignancy and in 38 patients with confirmed malignancy. The type, location, and intensity of tracer accumulation were compared on the planar and SPECT scans. The malignant or benign nature of lesions was proved by radiologic methods, histologic findings, 6 month follow-up, or all of these.
RESULTS: More metastases were detected by SPECT (SPECT, 58 of 64; planar, 42 of 64; P < 0.01). In three of seven patients with known malignancy who had a normal result of planar scan, only SPECT detected metastases. Fifty-nine metastases were radiologically mainly osteolytic, one was osteoblastic and four were mixed. Most lesions showed increased radioactivity (40 of 42 on planar scans vs. 45 of 58 on SPECT) and 2 of 42 (5%) vs. 12 of 58 (21%) were cold with marginally increased uptake. One of 58 metastases was a cold lesion seen on SPECT only. Lesions were more often malignant than benign when seen on SPECT in a pedicle (n = 5; malignant = 3, benign = 2), in the body and pedicle (n = 22; malignant = 14, benign = 8), within the vertebral body (n = 5; malignant = 4, benign = 1) and in the whole vertebra (n = 6; malignant = 4, benign = 2). The lesion to background ratio was higher on SPECT than on planar scans (SPECT, 2.26; planar scans, 1.86; P < 0.05 in malignant lesions).
CONCLUSIONS: SPECT of the spine improved the diagnostic accuracy of bone scans when added to a planar scan in patients with known malignancy and clinical suspicion of spinal metastases when the planar scan was borderline abnormal. It helps in differentiating between benign and malignant lesions of the spine.

Entities:  

Mesh:

Year:  1999        PMID: 10361935     DOI: 10.1097/00003072-199906000-00006

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  8 in total

1.  Premature conclusions may harm good ideas.

Authors:  Anton Staudenherz; Helmut Sinzinger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05       Impact factor: 9.236

Review 2.  Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.

Authors:  Hui-Lin Yang; Tao Liu; Xi-Ming Wang; Yong Xu; Sheng-Ming Deng
Journal:  Eur Radiol       Date:  2011-09-02       Impact factor: 5.315

Review 3.  Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT.

Authors:  Tao Liu; Shenghao Wang; Hao Liu; Bin Meng; Feng Zhou; Fan He; Xiaojian Shi; Huilin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-17       Impact factor: 4.553

4.  Repeatability of Radiotracer Uptake in Normal Abdominal Organs with ¹¹¹In-Pentetreotide Quantitative SPECT/CT.

Authors:  Steven P Rowe; Esther Vicente; Nadège Anizan; Hao Wang; Jeffrey P Leal; Martin A Lodge; Eric C Frey; Richard L Wahl
Journal:  J Nucl Med       Date:  2015-05-14       Impact factor: 10.057

5.  Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study.

Authors:  Naotoshi Ota; Katsuhiko Kato; Shingo Iwano; Shinji Ito; Shinji Abe; Naotoshi Fujita; Keiichi Yamashiro; Seichi Yamamoto; Shinji Naganawa
Journal:  Br J Radiol       Date:  2014-02       Impact factor: 3.039

6.  Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.

Authors:  Stefan Krüger; Andreas K Buck; Felix M Mottaghy; Ellen Hasenkamp; Sandra Pauls; Christian Schumann; Thomas Wibmer; Tobias Merk; Vinzenz Hombach; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-06       Impact factor: 9.236

7.  Current state of bone scintigraphy protocols and practice in Japan.

Authors:  Hajime Ichikawa; Kenta Miwa; Koichi Okuda; Takayuki Shibutani; Toyohiro Kato; Akio Nagaki; Hiroyuki Tsushima; Masahisa Onoguchi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020

Review 8.  Bone metastases in thyroid cancer.

Authors:  Nicole M Iñiguez-Ariza; Keith C Bible; Bart L Clarke
Journal:  J Bone Oncol       Date:  2020-02-19       Impact factor: 4.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.